Clinical Trial Update: Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD

View source ↗

Summary

A completed epidemiological study sponsored by AstraZeneca evaluating the symptoms, patterns of diagnosis, and treatment of gastroesophageal reflux disease (GER…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Status: COMPLETED